LEO Pharma AS - Product Pipeline Review - 2016 - PowerPoint PPT Presentation

About This Presentation
Title:

LEO Pharma AS - Product Pipeline Review - 2016

Description:

‘LEO Pharma A/S - Product Pipeline Review - 2016’, provides an overview of the LEO Pharma A/S’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by LEO Pharma A/S, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Read More At: – PowerPoint PPT presentation

Number of Views:69
Slides: 6
Provided by: SahilDubey

less

Transcript and Presenter's Notes

Title: LEO Pharma AS - Product Pipeline Review - 2016


1
LEO Pharma AS - Product Pipeline Review - 2016
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE 1 (503) 894-6022E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview
LEO Pharma A/S - Product Pipeline Review -
2016, provides an overview of the LEO Pharma
A/Ss pharmaceutical research and development
focus. The report provides comprehensive
information on the therapeutics under development
by LEO Pharma A/S, complete with analysis by
stage of development, drug target, mechanism of
action (MoA), route of administration (RoA) and
molecule type. The report also covers the
descriptive pharmacological action of the
therapeutics, its complete research and
development history and the dormant and
discontinued projects. report features
investigational drugs from across globe covering
over 20 therapy areas and nearly 3,000
indications. The report is built using data and
information sourced from databases, websites,
clinical trial registries, conferences, SEC
filings, investor presentations and featured
press releases from industry-specific third party
sources. Drug profiles featured in the report
undergoes periodic review following a stringent
set of processes to ensure that all the profiles
are updated with the latest set of information.
Additionally, various dynamic tracking processes
ensure that the most recent developments are
captured on a real time basis. The report helps
in identifying and tracking emerging players in
the market and their portfolios, enhances
decision making capabilities and helps to create
effective counter strategies to gain competitive
advantage. Read More At http//www.researchbeam.c
om/leo-pharma-as-product-pipeline-review-2016-mark
et
3


Report Overview
  • Scope
  • The report provides a snapshot of the pipeline
    therapeutic landscape of LEO Pharma A/S
  • The report provides overview of LEO Pharma A/S
    including its business description, key facts,
    and locations and subsidiaries
  • The report features descriptive drug profiles for
    the pipeline products which includes, product
    description, descriptive MoA, RD brief,
    licensing and collaboration details other
    developmental activities
  • The report assesses LEO Pharma A/Ss pipeline
    therapeutics based on drug target, mechanism of
    action (MoA), route of administration (RoA) and
    molecule type
  • Reasons to buy
  • Evaluate LEO Pharma A/Ss strategic position with
    total access to detailed information on its
    product pipeline
  • Gain strategically significant competitor
    information, analysis, and insights to formulate
    effective RD strategies
  • Identify potential new clients or partners in the
    target demographic
  • Devise corrective measures for pipeline projects
    by understanding LEO Pharma A/Ss pipeline depth
    and focus of pipeline therapeutics
  • Read More At http//www.researchbeam.com/leo-phar
    ma-as-product-pipeline-review-2016-market

4


Table of Content
List of Tables LEO Pharma A/S, Key Information
6 LEO Pharma A/S, Key Facts 6 LEO Pharma A/S -
Pipeline by Indication, 2016 9 LEO Pharma A/S -
Pipeline by Stage of Development, 2016 10 LEO
Pharma A/S - Monotherapy Products in Pipeline,
2016 11 LEO Pharma A/S - Combination Treatment
Modalities in Pipeline, 2016 12 LEO Pharma A/S -
Partnered Products in Pipeline, 2016 13 LEO
Pharma A/S - Partnered Products/ Combination
Treatment Modalities, 2016 14 LEO Pharma A/S -
Pre-Registration, 2016 15 LEO Pharma A/S -
Preclinical, 2016 19 LEO Pharma A/S - Discovery,
2016 20 LEO Pharma A/S - Pipeline by Target, 2016
36 LEO Pharma A/S - Pipeline by Route of
Administration, 2016 37 LEO Pharma A/S - Pipeline
by Molecule Type, 2016 38 LEO Pharma A/S -
Pipeline Products by Mechanism of Action, 2016
39 LEO Pharma A/S - Recent Pipeline Updates, 2016
40 LEO Pharma A/S - Dormant Developmental
Projects,2016 43 LEO Pharma A/S - Discontinued
Pipeline Products, 2016 44 LEO Pharma A/S,
Subsidiaries 46 Enquire More At
http//www.researchbeam.com/leo-pharma-as-product-
pipeline-review-2016-market/enquire-about-report
5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/leo-pharma-as-product-
pipeline-review-2016-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE 1 (800) 910-6452 DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com
Write a Comment
User Comments (0)
About PowerShow.com